ArticleThoracic cancer2014
Demonstration program of population-based lung cancer screening in China: Rationale and study design.
Article in Thoracic cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Meta analysis of the diagnostic value of circulating miRNA in benign and malignant pulmonary nodules.World journal of surgical oncology · 2023Pooled it
- Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.Oncotarget · 2017Pooled it
- [China National Guideline of Classification, Diagnosis and Treatment for Lung Nodules (2016 Version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2016Guideline
- [China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2025 Version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025Article
- Immune checkpoint blockers plus chemotherapy as the first-line treatment for advanced or metastatic squamous non-small-cell lung carcinoma: a network meta-analysis and economic evaluation.Frontiers in pharmacology · 2025Article
- Construction of a risk prediction model for isolated pulmonary nodules 5-15 mm in diameter.Translational lung cancer research · 2024Article
- Gender-specific outcomes of low-dose computed tomography screening for lung cancer detection: A retrospective study in Chinese never-smoker population.Cancer medicine · 2024Article
- Lung cancer incidence and mortality in trend and prediction between 2012-2030 in Shandong Province, using a Bayesian age-period-cohort model.Frontiers in oncology · 2024Article
- The impact of low-dose CT on smoking behavior among non-smokers, former-smokers, and smokers: A population-based screening cohort in rural China.Cancer medicine · 2023Article
- Poor sleep quality association with higher lung cancer risk: a nested case-control study.PeerJ · 2023Article
- Epidemiological trends and incidence prediction of lung cancer in China based on the Global Burden of Disease study 2019.Frontiers in medicine · 2022Article
- The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer.Frontiers in oncology · 2022Article
- Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screening.Journal of the National Cancer Center · 2021Article
- Should sublobar resection be offered for screening-detected lung nodules?Translational lung cancer research · 2021Review
- Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.Nature reviews. Clinical oncology · 2021Review
- Participation and Yield of a Lung Cancer Screening Program in Hebei, China.Frontiers in oncology · 2021Article
- The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.Nature cancer · 2020Review
- [Progress of Lung Cancer Screening with Low Dose Helical Computed Tomography].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020Review
- Association of cancer screening and residing in a coal-polluted East Asian region with overall survival of lung cancer patients: a retrospective cohort study.Scientific reports · 2020Article
- Clinical characteristics of resected solitary ground-glass opacities: Comparison between benign and malignant nodules.Thoracic cancer · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer is the leading cause of cancer-related death and has become an enormous economic burden in China. Low-dose spiral computed tomography (LDCT) screening could reduce lung cancer mortality. The feasibility of conducting a population-based lung cancer screening with LDCT in China is uncertain.
methodsIn 2010, a demonstration program of lung cancer screening was initiated in China. High-risk individuals were enrolled in a cluster sampling design in different centers. Participants received baseline and annual screening with spiral CT and follow-up information was collected. The objective of this program is to evaluate the feasibility of conducting population-based LDCT lung cancer screening in the Chinese context. The rates of detection, early diagnosis and treatment are defined as indicators of program performance. The optimal management strategies for nodules are explored in the Chinese context based on experiences in other studies overseas.
resultsA demonstration program of ongoing prospective, multi-center, population-based lung cancer screening is being performed in China.
conclusionsThis demonstration program will provide opportunities to explore the feasibility of LDCT lung cancer screening in the Chinese setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.